GSK Settles On Paxil Data Disclosure, Will Post Past Study Results By 2006
Executive Summary
GlaxoSmithKline will post summaries of studies conducted since the merger of Glaxo Wellcome and SmithKline Beecham by the end of 2005 under a settlement with New York Attorney General Eliot Spitzer
You may also be interested in...
Negative Antidepressant Trial Results See Low Publication Rate, Study Finds
The vast majority of antidepressant clinical trials viewed by FDA as having negative or questionable results are either not published in medical journals or published in a way that conveys a positive outcome, according to results of a study published in the January 17 issue of the New England Journal of Medicine
Negative Antidepressant Trial Results See Low Publication Rate, Study Finds
The vast majority of antidepressant clinical trials viewed by FDA as having negative or questionable results are either not published in medical journals or published in a way that conveys a positive outcome, according to results of a study published in the January 17 issue of the New England Journal of Medicine
ClinicalTrials.Gov Compliance Varies By FDA Review Division, Report Finds
Industry participation in HHS' ClinicalTrials.gov database fluctuated widely by FDA review division, according to an agency report on the progress of implementing the federally-mandated database